Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Thalidomide to Patients With Previously Untreated Multiple Myeloma

This study has been completed.
Sponsor:
Collaborators:
The Research Council of Norway
Nordic Myeloma Study Group, Germany
Information provided by (Responsible Party):
Norwegian University of Science and Technology
ClinicalTrials.gov Identifier:
NCT00218855
First received: September 20, 2005
Last updated: March 6, 2014
Last verified: March 2014